Medtronic, DaVita forming kidney tech company to develop dialysis delivery systems -
The healthtech and the dialysis provider will be 50-50 partners in the venture, which will include the entirety of Medtronic’s renal care business: renal access and acute and chronic therapy devices, as well as pipeline products, R&D teams and manufacturing facilities. However, Medtronic notes that neither the AV access portfolio nor the peripheral vascular health business are included in the collaboration. Ven Manda, president of Medtronic’s renal care segment, will take on the role of chief executive of the new firm, which won’t be named until the deal closes, likely in the next 12 months.
Please see full publication below for more information.